Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats.

Lingscheid T, Poeppl W, Bernitzky D, Veletzky L, Kussmann M, Plasenzotti R, Burgmann H.

Antimicrob Agents Chemother. 2015 Feb;59(2):859-63. doi: 10.1128/AAC.04246-14. Epub 2014 Nov 17.

2.

Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.

Poeppl W, Lingscheid T, Bernitzky D, Schwarze UY, Donath O, Perkmann T, Kozakowski N, Plasenzotti R, Reznicek G, Burgmann H.

Antimicrob Agents Chemother. 2014 Sep;58(9):5111-6. doi: 10.1128/AAC.02720-13. Epub 2014 Jun 16.

3.

Assessing pharmacokinetics of different doses of fosfomycin in laboratory rats enables adequate exposure for pharmacodynamic models.

Poeppl W, Lingscheid T, Bernitzky D, Donath O, Reznicek G, Zeitlinger M, Burgmann H.

Pharmacology. 2014;93(1-2):65-8. doi: 10.1159/000357569. Epub 2014 Feb 5.

PMID:
24503567

Supplemental Content

Loading ...
Support Center